Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gastroesophageal Junction Neoplasms”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00891878
What this trial is testing

Capecitabine With or Without Sunitinib Malate as First-Line Therapy in Treating Patients With Metastatic Cancer of the Esophagus or Gastroesophageal Junction

Who this might be right for
Adenocarcinoma of the Gastroesophageal JunctionEsophageal Cancer
Alliance for Clinical Trials in Oncology 12
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06439550
What this trial is testing

Adjuvant Treatment With Serplulimab，Trastuzumab and SOX in the HER-2 Positive GC/GEJC

Who this might be right for
HER2-positive Gastric Cancer
The First Affiliated Hospital of Zhengzhou University 42
Large-scale testing (Phase 3)Study completedNCT02625610
What this trial is testing

Avelumab in First-Line Maintenance Gastric Cancer (JAVELIN Gastric 100)

Who this might be right for
Unresectable, Locally Advanced or Metastatic, Adenocarcinoma of the Stomach, or of the Gastro Esophageal Junction
EMD Serono Research & Development Institute, Inc. 499
Testing effectiveness (Phase 2)Looking for participantsNCT07551362
What this trial is testing

Dual-target CLDN18.2/HER2 CAR-NK Cells for Advanced Gastric/GEJ Cancer

Who this might be right for
Advanced Gastric AdenocarcinomaAdvanced Gastroesophageal Junction Adenocarcinoma
Beijing Biotech 36
Testing effectiveness (Phase 2)UnknownNCT03271073
What this trial is testing

Apatinib Combined With S1 in Patients With Advanced Gastric Cancer

Who this might be right for
Gastric Cancer
Beijing Friendship Hospital 20
Early research (Phase 1)UnknownNCT05009966
What this trial is testing

Study of SYSA1801 in the Treatment of Claudin( CLDN) 18.2 Positive Advanced Malignant Solid Tumor

Who this might be right for
Advanced Solid TumorGastric Cancer (GC)Gastroesophageal Junction (GEJ) Cancer+1 more
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 272
Testing effectiveness (Phase 2)Looking for participantsNCT06962137
What this trial is testing

Phase II RAINSPOT: Zolbetuximab-Paclitaxel-Ramucirumab for CLDN18.2 Positive Gastro-esophageal Cancer

Who this might be right for
Gastric Cancer Adenocarcinoma MetastaticGastric Adenocarcinoma and Gastroesophageal Junction Adenocarcinoma
Universitaire Ziekenhuizen KU Leuven 100
Not applicableUnknownNCT06486545
What this trial is testing

Liposomal Irinotecan Combination Regimen for Second-line Treatment of Advanced Gastric Cancer

Who this might be right for
Advanced Gastric Cancer
Hunan Cancer Hospital 18
Testing effectiveness (Phase 2)Looking for participantsNCT07655024
What this trial is testing

TAIC FOLFOX for Locally Advanced G/GEJA

Who this might be right for
Gastric Cancer (Diagnosis)Gastroesophageal Junction Adenocarcinoma
Guang'anmen Hospital of China Academy of Chinese Medical Sciences 31
Not applicableStudy completedNCT04609813
What this trial is testing

Esophageal cAncer Screening Trial

Who this might be right for
Esophageal Squamous Cell CarcinomaEsophageal CancerGastroesophageal Junction Adenocarcinoma
Changhai Hospital 14,597
Not applicableLooking for participantsNCT06846996
What this trial is testing

Real-world Effectiveness and Safety of Trastuzumab Deruxtecan in Patients With Locally Advanced or Metastatic HER2-positive Gastric or Gastroesophageal Junction Adenocarcinoma in China

Who this might be right for
HER2-positive Gastric CancerHER2-positive Gastroesophageal Junction
Daiichi Sankyo 260
Not applicableStudy completedNCT02722785
What this trial is testing

PeRioperative Study of Exercise Training in Patients With Operable Cancer of the Gastroesophageal Junction

Who this might be right for
Gastro-esophageal Cancer
Jesper Frank Christensen, PhD 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07507916
What this trial is testing

Dynamic ctDNA-Guided Adjuvant Therapy in cStage III and IVA Gastric or Gastroesophageal Junction Adenocarcinoma

Who this might be right for
ctDNAGastric CancerGastroesophageal Junction (GEJ) Adenocarcinoma+1 more
Fudan University 32
Testing effectiveness (Phase 2)UnknownNCT05964543
What this trial is testing

The Safety and Efficacy of Q-1802 Combined With XELOX in Gastrointestinal Tumors

Who this might be right for
Gastroesophageal Junction (GEJ) Adenocarcinoma
QureBio Ltd. 72
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07266025
What this trial is testing

Adebrelimab Combined With Induction Chemotherapy or SHR-8068 for Mismatch Repair-Deficient/Microsatellite Instability-High (dMMR/MSI-H) Locally Advanced Gastric/Gastroesophageal Junction Adenocarcinoma：A Randomized, Non-comparative Phase 2 Study

Who this might be right for
Gastric AdenocarcinomaGastroesophageal AdenocarcinomaMismatch Repair Deficient or MSI-High Solid Tumors+1 more
Shanghai Zhongshan Hospital 30
Early research (Phase 1)Not Yet RecruitingNCT07036185
What this trial is testing

A Clinical Trail of KJ015 in Patients With HER2-Expressing Solid Tumors

Who this might be right for
Gastric/Gastroesophageal Junction CancerBreast CancerColorectal Cancer+3 more
Shanghai Bao Pharmaceuticals Co., Ltd. 66
Not applicableNot Yet RecruitingNCT05954117
What this trial is testing

Chemotherapy in the Context of Esophageal and Gastroesophageal Junction Cancer Cachexia

Who this might be right for
Esophageal Adenocarcinoma
University Hospital, Clermont-Ferrand 60
Early research (Phase 1)Study completedNCT04580485
What this trial is testing

INCB106385 Alone or in Combination With Immunotherapy in Advanced Solid Tumors

Who this might be right for
Ovarian CancerBladder CancerNon Small Cell Lung Cancer+8 more
Incyte Corporation 54
Large-scale testing (Phase 3)Looking for participantsNCT05188313
What this trial is testing

TRAstuzumab and Pertuzumab for HER2+ Resectable Oesophageal Cancer

Who this might be right for
Esophageal CancerEsophageal Adenocarcinoma
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 376
Large-scale testing (Phase 3)Study completedNCT03933449
What this trial is testing

Study of Pembrolizumab (MK-3475) Versus Investigator's Choice of Chemotherapy for Participants With Advanced Esophageal/Esophagogastric Junction Carcinoma That Progressed After First-Line Therapy (MK-3475-181/KEYNOTE-181)-China Extension Study

Who this might be right for
Esophageal CarcinomaEsophagogastric Junction Carcinoma
Merck Sharp & Dohme LLC 123
Next Page